BeOne's Solid Tumor organization is focused on advancing novel therapies in Breast/Gynecological, Gastrointestinal (GI), and Lung Cancers. The company has advanced over 20 clinical candidates in the past three years and will present proof-of-concept data on 5 assets before the end of 2026. Within the GI franchise, BeOne presented proof-of-concept data for its GPC3x41BB bispecific antibody in late-line HCC patients at ASCO 2026. A Global Product Team (GPT) has been formed to execute registration-intent studies for this molecule, and a corresponding Global Brand Team (GBT) is being established to support successful global commercial launches. This role will serve as the Global Commercial Lead (GCL) for this asset, driving launch preparations and readiness across global functions and affiliate partners. The GCL will mobilize the first GBT for the GI franchise, comprising members from various functions and markets, to create the first global brand plan for this asset. This plan will define the opportunity size, commercial strategies, and tactical plans for successful global commercial launches. The ideal candidate will be a visionary leader at the R&D and commercial interface, collaborating closely with cross-functional teams to align with business objectives and market needs across BeOne Regions. This role requires a deep understanding of drug development and commercialization, strong leadership, and a proven track record in leading matrix teams through product launch and lifecycle management planning. The role reports to the Vice President, Global Commercial Strategy & Operations (GCSO), Solid Tumors.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive